Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 December 2019 | Story Nonsindiso Qwabe | Photo Barend Nagel
Victoria Read more
Victoria the mannequin has become a familiar face in Nursing classrooms

She has an uncanny ability to move her eyes towards the sound of voices in a room, her voice shrills and squeals when she's in pain, she throws in a Spanish word or two, and she releases bodily fluids just like a real human would. 

These are just some of the quirky characteristics that make up the new R1,76 million-rand birthing mannequin in the School of Nursing's Simulation Unit, who goes by the name Victoria. She weighs more than 80 kg and is almost 1,7 metres high. With features such as real eyelashes, eyebrows, and hair, you can't help but do a double take when you lay eyes on her. 

Students getting practical experience

While the unit has other mannequins used for training Nursing students in each year or their study, Simulation Coordinator from the School of Nursing in the Faculty of Health Sciences, Cecile Fourie, said Victoria was a major upgrade for the school because of her versatility. Victoria would further enhance the school's quality of teaching by training students in their final year of undergraduate studies as well as those pursuing their postgraduate studies, about the ins and outs of pregnancy and other female morbidities, Fourie said. 

"We try to make our scenarios as real and authentic as possible and we've seen how much our students have grown. Introducing Victoria to our pre- and postgraduate students will prepare them to be competent in clinical practice." 

Meet Victoria

So, what exactly can Victoria do? 

Fourie said while the other mannequins were made with screws that made them look robot-like, Victoria was made with silicone and given a clean finish to make her appear life-like. The other mannequins can only blink, but Victoria's eyes move around, she can speak Spanish and French, and she comes with five tummies for different medical scenarios. She has a normal tummy which acts as a closure, an operable tummy for caesarean delivery, a tummy that allows a breeched baby to be twisted and turned from the outside just before delivery, a contraction tummy used for normal vaginal delivery – which also allows Victoria to push, bleed, urinate, and release mineral oil which acts as amniotic fluid. The fifth tummy is postpartum haemorrhage, a condition that is common among South African mothers after delivery. 

"It’s so good that we get to train our students in such real, lifelike circumstances. Through Victoria we're going to try and do our part in lessening maternal deaths, which are so prominent in our country. She can act out all the abnormalities that take place in a real delivery, and she can also have other medical conditions such as a heart attack," Fourie said.



News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept